Research Triangle Park (RTP) is widely recognized as one of the foremost innovation hubs in the United States. Situated ...

An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

On Oct. 26, 1944, after four days of furious fighting, the World War II battle of Leyte Gulf, largest air-naval clash in ...

The statement read: “NAFDAC enforcement officers, aided by intelligence from the Nigerian Army’s 15 Field Engineering ...

The growth of the DEE treatment market can be attributed to the increasing prevalence of developmental and epileptic ...

The growth of the Chronic Hepatitis B Virus Testing market can be attributed to several key factors, including significant ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £15.50. The company’s shares opened today at ...

Bank of America Securities analyst Graham Parry has maintained their bearish stance on GSK stock, giving a Sell rating on October 9. Graham ...

Last week, GlaxoSmithKline and Northwestern University filed separate lawsuits against Moderna, accusing its mRNA-based vaccines of ...

Today, Cerebras Systems, the pioneer in high performance AI compute, smashed its previous industry record for inference, delivering 2,100 tokens/second performance on Llama 3.2 70B. This is 16x faster ...

Dr. Ernest Mario, a leader in the pharmaceutical industry, passed away at his son’s home in Durham, NC, on October 20, 2024, ...